Filing Details
- Accession Number:
- 0000899243-22-038621
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 17:00:37
- Reporting Period:
- 2022-12-13
- Accepted Time:
- 2022-12-15 17:00:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1851194 | Ventyx Biosciences Inc. | VTYX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1394208 | W Christopher Krueger | C/O Ventyx Biosciences, Inc. 662 Encinitas Blvd, Suite 250 Encinitas CA 92024 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-12-13 | 30,000 | $34.46 | 272,692 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 30,000 shares sold in the price range of $34.10 to $34.82. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.